Other concerning symptoms that necessitate medical consultation include: Severe abdominal distension or inability to pass gas/stool (possible ileus or bowel obstruction) Nausea that worsens rather than improves after 812 weeks Inability to maintain adequate nutrition or hydration Unintentional weight loss exceeding clinical targets New or worsening heartburn or reflux symptoms Visual changes (especially with rapid blood sugar improvement) Severe headache or altered mental status Signs of gallbladder disease (right upper quadrant pain, especially after eating) Hypoglycemia symptoms if taking insulin or sulfonylureas Patients should generally not discontinue GLP-1 medications without medical guidance, except in emergencies such as suspected pancreatitis or severe allergic reaction
These trials demonstrate the medications long-term potential for weight loss
*Correspondence: Lekha Sleno [email protected] This article was submitted to Analytical Chemistry, a section of the journal Frontiers in Chemistry Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Support your mental wellness Losing weight can help reduce stress, boost mood, and support overall emotional well-being
The most effective strategy is prevention: consistent reminders, visible medication storage, and reliable dose tracking keep your treatment on course and your progress moving forward
One notable interaction is with nitroglycerin, which is used to increase blood flow by dilating blood vessels